patent/UA-11575-U

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79bf71ff8a095a26fc8e40fe883223a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f140361615a956e8b226485556e8bab
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
filingDate	2004-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd7ec8b682ec5595cc0970e448db477a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f12b536eaefdac72b1f57e931109a6d
publicationDate	2006-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	UA-11575-U
titleOfInvention	Method for treating primary erysipelas
abstract	The method for treating primary erysipelas comprises the use of antibacterial substances of broad spectrum, antihistamine drugs, Ascorutin, Amison, Cycloferon, Manax. Physiotherapy is also employed. In addition, Glutargin is used.
priorityDate	2004-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38072 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54692995 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20317 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453151858 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415722814 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452511130

Total number of triples: 19.